Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-510 plus chemotherapy in advanced NSCLC
NCT00061646Phase 2Terminated
- Sponsor
- Abbott Laboratories
- Start
- Mar 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abt-510 in non-small cell lung cancer (NSCLC), sponsored by Abbott Laboratories. Started Mar 2003; status: terminated.
02
Drugs
abt-510
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00061646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061646.